Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study.
Carson JM, Barbieri S, Cunningham E, Mao E, van der Valk M, Rockstroh JK, Hellard M, Kim A, Bhagani S, Feld JJ, Gane E, Thurnheer MC, Bruneau J, Tu E, Dore GJ, Matthews GV, Martinello M; REACT study group.
HIV + AIDS Injecting Drug Use
Identifying the Most Effective Recruitment Strategy Using Financial Reimbursements for a Web-Based Peer Network Study With Young People Aged 16-18 Years: Protocol for a Randomized Controlled Trial.
Raggatt M, Wright CJC, Sacks-Davis R, Dietze PM, Hellard ME, Hocking JS, Lim MSC
Young People's Health
Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysis.
Traeger MW, Harney BL, Sacks-Davis R, van Santen DK, Cornelisse VJ, Wright EJ, Hellard ME, Doyle JS, Stoové MA
Hepatitis C Sexually Transmitted Infections (STI's)
COVID-19 disaster recovery capitals: A conceptual framework to guide holistic and strengths-based support strategies
Quinn P, Munari S, Block K, Walker S, Liberman J, Wallace J, Horyniak D, Oliver J, Hellard M, Fletcher-Lartey S, Gibbs L
COVID-19
Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis.
Koopsen J, Matthews G, Rockstroh J, Applegate TL, Bhagani S, Rauch A, Grebely J, Sacks-Davis R, Ingiliz P, Boesecke C, Rebers S, Feld J, Bruneau J, Martinello M, Hellard M, Dore GJ, Schinkel J, van der Valk M, REACT Study Group
Hepatitis C
Lives saved by public health restrictions over the Victorian COVID-19 Delta variant epidemic wave, Aug-Nov 2021.
Delport D, Sacks-Davis R, Abeysuriya RG, Hellard M, Scott N
COVID-19